Suchergebnisse - "Olmos, D"

PubPharm (11)

1

SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2018

von Cassinello, J. | Arranz, J. | Piulats, J. | +7

ErratumIn: Clin Transl Oncol. 2018 Jan 5;:. - PMID 29305743

2

Management of patients with advanced prostate cancer : recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Gillessen, S. | Omlin, A. | Attard, G. | +41

CommentIn: Ann Oncol. 2015 Nov;26(11):2354. - PMID 26216387

3

Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials : a subset analysis of a European Phase I database

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Cassier, P. | Polivka, V. | Judson, I. | +14

4

Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Sandhu, S. | Omlin, A. | Hylands, L. | +21

5

Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone : clinical evidence for cross-resistance?

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Mezynski, J. | Pezaro, C. | Bianchini, D. | +13

6

Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents : a single centre experience

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Molife, L. | Alam, S. | Olmos, D. | +8

CommentIn: Ann Oncol. 2012 Aug;23(8):1934-6. - PMID 22510374

7

A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Arkenau, H. | Plummer, R. | Molife, L. | +9

8

First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours

enthalten in: British journal of cancer | 2012

von Yap, T. | Cortes-Funes, H. | Shaw, H. | +16

9

The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours : results of a phase Ib dose-escalation, open-label study

enthalten in: British journal of cancer | 2010

von Molife, L. | Fong, P. | Paccagnella, L. | +15

10

Clinical benefit in Phase-I trials of novel molecularly targeted agents : does dose matter?

enthalten in: British journal of cancer | 2009

von Postel-Vinay, S. | Arkenau, H. | Olmos, D. | +7